
The tremendous advances achieved in the understanding of cancer biology have delivered unprecedented progress in zzso targeted cancer therapy in the past zzso The fast growing category of targeted zzso agents available for clinical use is accompanied by a conceptual revolution in zzso drug zzso Nevertheless, zzso targeted cancer therapy remains challenged by a high failure rate and an extremely small proportion of patients that can zzso It is pivotal to take lessons from the past and seek new zzso This review discusses conceptual progress and remaining challenges in zzso targeted cancer therapy, and proposes feasible alternatives to increase chances of clinical success in the zzso 

